In addition, deletion of the novel biomarker CPT1C induced mitochondrial dysfunction, leading to senescence-like growth inhibition and cellular senescence in six cancer cell types, including pancreatic cancer cells, and inhibited cancer growth in vivo (37). The gene discussed is CPT1C; the disease is cancer.